8. Immune System and Malignant Disease - guidance
To access BNF Formulary section click on the link under BNF Section/s
To access the Guidance Document click on the highlighted text under the Title column
Use documents past their review date with Caution
|
BNF Section/s |
Title | Issuing Body | Date of Issue | Update Due |
| 8.2.3 | Interferon | High-Cost Drugs | - | - |
| 8.1 | Methotrexate - Oral Methotrexate Kent and Medway Position Statement | Kent & Medway CCG | Dec 2020 |
Jun 2022
|
| 8.2.1 | Mycophenolate mofetil - Safety Alert - Mycophenolate mofetil |
MHRA Drug Safety Update |
Dec 2015 | - |
- First Line Choice
- On Formulary
- Specialist Initiation Only
- Hospital Only
- KMPT Initiation Only